Biel Corporation (BioElectronics Corporation) has recently announced significant commercial activity and infrastructure expansion tied to its ActiPatch product, which strongly suggests increasing demand.
Commercial rollout and market strategy
In June 2026, Biel entered the execution phase of a strategic distribution and licensing agreement with Electrome Corporation, under which Electrome will market and distribute ActiPatch and other BioElectronics products
NewMediaWire
NewMediaWire
. Electrome is preparing an aggressive consumer launch strategy using AI-driven marketing, digital outreach, and scalable e-commerce to accelerate awareness and adoption of ActiPatch in the U.S.
NewMediaWire
NewMediaWire
.
Operational expansion to meet demand
On July 21, 2026, Biel announced it had doubled its facility space to support Electrome’s direct-to-consumer ActiPatch launch. The new storage and fulfillment center will handle inventory receiving, order processing, packing, shipping, and returns for ActiPatch and related products
markets.financialcontent.com
markets.financialcontent.com
. This move is explicitly described as being in response to anticipated increased orders from the new sales channel.
Implication for order trends
The combination of a major go-to-market push, AI-enhanced consumer engagement, and a dedicated fulfillment expansion indicates that Biel is positioning for higher sales volumes. While the announcement does not provide exact order numbers, the scale of the infrastructure investment and the timing of the rollout suggest that product orders for ActiPatch are expected to rise as the direct-to-consumer campaign launches.
Bottom line
Based on the company’s public statements, the new partnership, and the facility expansion, orders for ActiPatch are likely increasing as Biel prepares for a large-scale consumer launch in the U.S. market
NewMediaWire
NewMediaWire
Always perform a due diligent investment review before making any investment decision.
.